Pfizer
Sharon Emma Macdermott is an experienced marketing professional with a strong background in the pharmaceutical and consumer healthcare industries. Currently serving as Director, Consumer Lead Prevnar 13 Pediatrics at Pfizer since November 2015, Sharon has also held the position of Director Lyrica Marketing at Pfizer, Inc. since July 2010. Previous roles include Innovation Manager at GlaxoSmithKline, Product Director at Johnson & Johnson Consumer Companies, and positions at Pfizer Consumer Healthcare and Warner Lambert. Sharon began their career as an Associate Brand Manager at The Dial Corporation. Academically, Sharon holds two Master of Business Administration (MBA) degrees, one in International Advertising from Thunderbird School of Global Management and another in Operations Management and Supervision from Arizona State University.
This person is not in the org chart
This person is not in any teams
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.